Pharmacology

Questioning the Long-Term Benefit of Aspirin in Patients with Diabetes

Fed Pract. 2010 February;27(2):35
PDF Download

 

Recommended Reading

Olmesartan Lowers Microalbuminuria in Type 2
Type 2 Diabetes ICYMI
TESST Predicts Cardiac Risk in Elderly Diabetics
Type 2 Diabetes ICYMI
Asians at Increased Risk for Gestational Diabetes
Type 2 Diabetes ICYMI
Societies Team Up for Diabetic Limb Salvage
Type 2 Diabetes ICYMI
Height Is a Risk Factor for Amputations
Type 2 Diabetes ICYMI
Heart Failure Increases New-Onset Diabetes Risk
Type 2 Diabetes ICYMI
Noninvasive CIMT Scan Predicts Poor Myocardial Perfusion
Type 2 Diabetes ICYMI
ADVANCE Yields More Data On Heart Risk in Diabetes
Type 2 Diabetes ICYMI
Comparing Antithrombotic Regimens for Diabetic Patients Undergoing PCI
Type 2 Diabetes ICYMI
The Role of Incretin-Based Therapies in Treating Patients with Type 2 Diabetes Mellitus
Type 2 Diabetes ICYMI